US Medical Innovations LLC (USMI), a U.S.-based biomedical device specification manufacturing company and subsidiary of US Patent Innovations LLC (USPI) has received a Japanese patent for its Canady Hybrid Plasma (CHP) technology in Japan. CHP simultaneously cuts and coagulates biological tissue, and is the primary intellectual property behind the Canady Hybrid Plasma Scalpel (CHPS), a device now beginning to secure a strong initial foothold in the U.S. surgical market. This approval by the JPO represents an important milestone for the company’s pending plans for international distribution.

The U.S. Food and Drug Administration (FDA)-registered CHPS is a smart multi-functional electrosurgical handpiece, which delivers a precise beam less than 1 mm in diameter and a depth of injury as low as 0.1 mm. The technology behind the CHPS decreases tissue damage, perioperative blood loss, operative time, blood transfusion rates, and helps surgeons perform total knee replacements without the use of a tourniquet. The CHPS incorporates four separate operating modes: hybrid plasma, argon plasma coagulation, conventional monopolar cut and coagulation, which can be used in a range of subspecialties, such as cardiovascular surgery, endoscopy, ENT, general surgery, gynecology, neurosurgery, orthopedics, plastics, surgical oncology, thoracic surgery and dermatology.

“The JPO patent grant provides critical intellectual property approval and protection for our products as we prepare to launch the company’s new sales program for the Japanese market, a landmark step in our global expansion strategy,” said Jerome Canady, M.D., CEO.

Takoma, Md.-based US Medical Innovations is a private FDA-registered U.S. biomedical device specification manufacturing company that develops advanced plasma electrosurgical devices. USMI’s products are designed for ambulatory and inpatient endoscopy centers as well as complex surgical procedures.

US Patent Innovations, USMI’s parent company, is a private investor-owned company founded by Canady whose main focus is to invest in new and innovative technologies in the fields of electrosurgery, plasma medicine and surgical devices.

Watch the video below to learn more about US Medical Innovations’ Canady Hybrid Plasma technology: